Real-time enrollment status for this high-risk prostate cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:32 AM UTC
| NCT Number | NCT03541928 |
| Recruiting Status | Recruiting |
| Condition | High-risk Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | The Methodist Hospital Research Institute |
| Last Updated on CT.gov | April 6, 2021 (Apr 6, 2021) |
As of September 1, 2026: Clinical trial NCT03541928 is currently recruiting participants. This phase2 study for high-risk prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by The Methodist Hospital Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03541928 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03541928 was last updated Apr 6, 2021 (April 6, 2021). HelloStudys verifies this status automatically.